THE USE OF MASTODYNON FOR PROPHILAXIS AND THERAPY OF THE PATIENTS WITH DYSHORMONAL HYPERPLASIA OF MAMMARY GLAND

The data on pathogenesis of dyshormonal hyperplasia of mammary gland providing rationale for the use of preparation Mastodynon (Bionorica AG) for treatment of such pathologies, are analyzed. Efficacy and safety of therapy with Mastodynon of the patients suffering from mastopathy, including these at the background of gynecological diseases, hronic inspecific pathology of hepatobiliary system, are shown.